Form 4 for ACRS Aclaris Therapeutics, Inc.
Accepted 2022-02-11 00:00:00 ET · period of report 2022-02-09 · accession 0001209191-22-008849 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-11 | 2022-02-09 | ACRS | Ruffo Frank | CFO | S - Sale | $12.66 | -1,388 | 172.4K | -0.8% | -$17.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-09 | S | D | 1,388 | $12.66 | 172,359 | D | — | — |